SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-22-022160
Filing Date
2022-09-12
Accepted
2022-09-12 08:27:29
Documents
13
Period of Report
2022-09-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K urgn20220909_8k.htm   iXBRL 8-K 27624
  Complete submission text file 0001437749-22-022160.txt   158890

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA urgn-20220908.xsd EX-101.SCH 3602
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE urgn-20220908_def.xml EX-101.DEF 11533
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE urgn-20220908_lab.xml EX-101.LAB 15415
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE urgn-20220908_pre.xml EX-101.PRE 11689
7 EXTRACTED XBRL INSTANCE DOCUMENT urgn20220909_8k_htm.xml XML 2567
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38079 | Film No.: 221237439
SIC: 2834 Pharmaceutical Preparations